The Architecture

The axioms explain why. The architecture is what gets built.

Institutional architecture is the design of the scientific, technical, operational, and organizational systems that let an institution turn evidence into delivery at scale. It begins with mission — the set point everything else is measured against — and is carried by four domains. Each one answers an axiom directly — and each is commissioned on its own or as part of a whole operating model.

Four Delivery Domains

01

Scientific Architecture

Research workflows, laboratory operations, assay and diagnostic development, translational science, and scientific quality systems. When research, laboratory, and clinical functions evolve independently, execution fragments — and the science is rarely the thing that failed.

Answers Axiom II — Every outcome is the expression of a system
Practiced at: Abcam — commercial mammalian cell line development inside an ISO-certified operation, spanning cell engineering, manufacturing and product development alongside the programme management, commercial, supply chain and quality functions around them.
02

Data Architecture

Scientific data integration, decision support, indicator and KPI design, executive dashboards, and portfolio analytics. Built deliberately, because the measure an institution adopts is the behavior it will get — the instrument is never neutral.

Answers Axiom IV — Measurement changes behavior
Practiced at: Leica Biosystems — operational and financial data turned into workforce and executive decisions across a national field organization. Separately, population-scale genetic analysis in R, Python, MySQL and Plink for the co-authored study of clock-gene variants in major depression and bipolar disorder.
03

Organizational Architecture

Governance models, decision rights, cross-functional operating models, program management, and the incentive design that determines what an institution actually rewards. Environment sets the ceiling; this domain is where the environment is drawn.

Answers Axioms I and V — Environment and incentive drift
Practiced at: Leica Biosystems — a national field organization: who decides what, at what cadence, and on whose information. SCORE, University of Oregon — five years strengthening retention and research participation in the biological sciences, by redesigning the conditions around a research path rather than advocating for it.
04

Commercial & Access Architecture

Product strategy, technical commercialization, customer and user insight, technology adoption, and the access and reimbursement pathways that decide whether a product reaches the people it was built for. Scale reaches a weak foundation faster than it reaches the market.

Answers Axiom III — Growth without structural integrity
Practiced at: Leica Biosystems — field operations across approximately 350 academic, biotechnology, pharmaceutical and research accounts, supporting new product introductions and customer implementation.

The Foundation

Beneath the four domains sits a fifth architecture that is not for sale: the biological one. Population genetics, systems biology, complex trait analysis, and the study of aging and stress response are where the axioms came from in the first place.

Living systems were the original case study. Outcomes as the expression of an underlying architecture, growth that outruns structural integrity, drift toward whatever the environment selects for — these are not business metaphors borrowed from biology. They are findings, carried across.

That is the difference between a set of principles and a set of aphorisms. The axioms are testable because they were tested somewhere first.

The record
Doctorate
Ph.D. in Biology, University of Oregon, Institute of Ecology & Evolution. Population genetics; transgenerational effects of dietary stress in Caenorhabditis elegans under Dr. Patrick Phillips.
Peer-reviewed publications
Molecular analyses of circadian gene variants and sex-dependent links between depression and clocks — Translational Psychiatry, 2016. Cardiac compensation for forced overload stress in adult zebrafish — BioResearch Open Access, 2012.
Systems studied
Population and statistical genetics, aging and stress-response networks, transgenerational inheritance, cardiovascular physiology, wound healing, astrocyte signaling, and viral capsid genetics — across four research institutions.
Operating record
Fourteen years spanning bench research, commercial cell line development, technical support, and national field operations leadership inside two Danaher operating companies.

Where This Work Applies

Two markets, chosen because they share a structure: each converts scientific evidence into regulated delivery at scale, and each fails in the same place when the architecture is missing.

Pharma
Emerging pharmaceutical companies, biotechnology, and precision medicine — from discovery through commercialization.
Diagnostics
Diagnostics developers, clinical laboratory organizations, life science tools, and medical devices.
The measurement layer

Each domain is assessed against leading indicators rather than outcomes. Those instruments are in development and will be published here.

See the instruments